clinical trials using psychedelics – A New Vision for Mental Health

Depression and Me

Author: Editorial 29th May 2019 0 Comments

In “Depression and Me” – a 1 hour TV programme from the BBC – Alastair Campbell talks candidly about his experiences of living with depression. And after 30 years of taking antidepressant drugs that haven’t stopped his depressions, he also explores whether radical…
Read more

collaborative practice

Alastair Campbell, BBC, clinical trials using psychedelics, deep therapy, depression, immune system, inflammation, neurofeedback, New Approaches, physical exercise, psychosis, resilience, transcranial magnetic stimulation (TMS)

Imperial launches world’s first Centre for Psychedelics Research

Author: Editorial 27th May 2019 0 Comments

Ryan O’Hare writes (April 23rd, 2019): “The first formal centre for psychedelic research in the world will launch at Imperial College London today. Funded by more than £3 million from five founding donors, the new Imperial Centre for Psychedelic Research will…
Read more

collaborative practice

Centre for Psychedelics Research, clinical trials using psychedelics, Dr Robin Carhart-Harris, Imperial College London, psychedelic drugs, Research, Ryan O'Hare

Psychiatry & the psychedelic drugs. Past, present & future

Author: Editorial 19th April 2019 0 Comments

Written by James Rucker, Jonathan Iliff and David Nutt, the abstract of this article (2017, Neuropharmacology) says: “The classical psychedelic drugs, including psilocybin, lysergic acid diethylamide and mescaline, were used extensively in psychiatry before they were placed in Schedule I of the…
Read more

collaborative practice

clinical trials using psychedelics, David Nutt, James Rucker, Jonathan Iliff, lysergic acid diethylamide (LSD), magic mushrooms, mescaline, Neuropharmacology, psilocybin, psychedelic drugs, psychoneurotic